Pharmacological Evaluation Institute of Japan (PEIJ), General Incorporated Association
"make a future together"
Pharmacological Evaluation Institute of Japan (PEIJ) is a non-profit pharmacology research institute. We are working with the activities globally for improvement in the reliability of the evaluation method of toxicity / safety and efficacy used in the case of drug development and chemical safety as an "ADAPTER". We are also working for STEAM education for all in the SDGs.
World Information:
[2020.10.15-16, ICH]
A public webinar (ICH WG Presentations and Live Q&A) was held to provide an overview of the high-level principles and rationale behind the new interconnected Q&As to ICH E14 and S7B and to answer questions received during the webinar. ICH website.
[2020.08.27, ICH]
The ICH stage 1 Q&As are now available on the ICH website.
[2018.11, CiPA]
[2018.09.30-10.2, PEIJ]
PEIJ makes a poster presentation, "New Approach for Neuropharmacology Profile: In-Situ Real-Time Neuropharmacology Monitoring by Imaging Technique Using the Molecularly Imprinted Polymers (MIPs)", at Safety Pharmacology Society 2018 Annual Meeting.
[2018.04.27, CiPA]
Results from a Blinded CiPA Pailot Study
[2018.03.04, PEIJ]
PEIJ has an advanced science program for younger generation. We started a "PEIJ Youth Science Lab" and junior/senior high school students are joining us as PEIJ Junior Researchers. They are enjoying their own research activity including thesis reading/writing, discussion with richly experienced researchers, awareness survey, cell culture, etc. We encourage PEIJ Junior Researchers to think for themselves.
World Topic: CiPA in Hindsight Roundtable Discussion
This roundtable discussion is presented by Ncardia and HESI and describes the current and evolving roles of human-induced pluripotent stem cell-derived cardiomyocytes and drug safety.
The ICH stage 1 Q&As are now available on the ICH website.